Pharmacognostical, Phytochemical and Pharmacological profile of Colebrookea oppositifolia Smith
Abstract
Colebrookea oppositifolia commonly known as ‘Bhaman’ is distributed throughout India from the Himalayas down to Deccan. The plant is used traditionally as such as dermatitis, dysentery, fever, headache, peptic ulcer, haemostatic, wounds, as anti-fertility agent, fungicide, and the roots of the plant has been most widely used for the treatment of epilepsy.. Medicinally, it has been proven to possess various pharmacological activities like treating corneal opacity or conjunctivitis, sore eyes due to its anti-inflammatory properties, cardioprotective, hepatoprotective, anti-inflammatory, antihelmintic, antifungal, antioxidant, antimicrobial, antinociceptive, cytotoxic activity, anticonvulsant, antiulcer, antimicrobial, anti-fertility, antipyretic and insecticide. Further, studies reveal the presence of various phytochemical constituents mainly flavone glycosides viz. chrysin, negletein, landenein; leaves contain 5,6,7- tri-methoxyflavone, 5,6,7,4'-tetramethoxyflavone, acteoside, and quercetin in the bark; root contains stearic, palmitic, oleic acids, triacontanol, flavone glycoside echioidin, 5,6,7-trimethoxyflavone and 4',5,6,7- tetra methoxy flavone; sugars and vitamins have also been isolated from this plant. These studies reveal that Colebrookea oppositifolia is a source of medicinally active compounds and have various pharmacological effects; hence, this drug encourage finding its new therapeutic uses.
Keywords: Colebrookea oppositifolia, wound healing, anticonvulsant, Lamiaceae
Downloads
References
2. Madhavan, V, Yadav DK, Gurudeva M and Yoganarasimhan S, Pharmacognostical studies on the leaves of Colebrookea oppositifolia Smith. A.Journal of Trad. Medicine., 2011; 6(4):134-144.
3. Rana TS, Ranade SA, The enigma of monotypic taxa and their Taxonomic implications, J. of Current science, 2009; 96(2):25.
4. Nadkarnii KM (1976) Indian Materia Medica (Vols I, II), Popular Prakasan Pvt. Ltd., Bombay, India.
5. Kritikar, K., Basu, B., 2007. Indian Medicinal Plants. International book Publishers, Bombay.
6. Viswanatha GL1, Venkataranganna MV2, Prasad NBL. Ameliorative potential of Colebrookea oppositifolia methanolic root extract against experimental models of epilepsy: Possible role of GABA mediated mechanism. Biomed Pharmacother. 2017; 90:455-465.
7. Riaz, T., Abbasi, M., Shahzadi, T., Rehman, A., Siddiqui, S., Ajaib, M. Colebrookea oppositifolia: A valuable source for natural antioxidants. J. Med. Plants Res. 2011; 5:4180-4187.
8. Subba, B., Basnet, P., Antimicrobial and Antioxidant Activity of Some Indigenous Plants of Nepal. J. Pharmacogn. Phytochem. 2014; 3:62-67.
9. Ghaisas, M., Sharma, S., Ganu, G., Limaye, R., Antiulcer Activity of Colebrookea oppositifolia Sm. Res. J. Pharmacol. Pharmacodynam. 2010; 2:66-70.
10. Pallab, K., Kush, B., Kumar, P., Girraj, T., Kishor, T., Singh, N., Kumar, S., Shivani, G., In vitro – in vivo evaluation of cardioprotective effect of the leaf extract of Colebrookea oppositifolia Sm. J. Global Trend. Pharm. Sci. 2011; 2:310-324.
11. Gupta, R.S., Yadav, R.K., Dixit, V.P., Dobhal, M.P., Antifertility studies of Colebrookea oppositifolia leaf extract in male rats with special reference to testicular cell population dynamics. Fitoterapia. 2001; 72:236-245.
12. Sharma, J., Gairola, S., Gaur, R.D., Painuli, R.M., Siddiqi, T.O., Ethnomedicinal plants used for treating epilepsy by indigenous communities of sub-Himalayan region of Uttarakhand, India. J. Ethnopharmacol. 2013; 150:353-370.
13. Das PK , Nath V, Gode KD and AK Sanyal. Preliminary Phytochemical and
Pharmacological studies on C. hirsutus Linn. Indian J Med Res: 1964; 52(3):300.
14. Roma Mitra. Bibliography on Pharmacognosy of Medicinal Plants .Lucknow: 1985; p.138-39.
15. Harborne JB. Phytochemical Methods. London: Chapmans Hall; 1973.
16. Usha kumari J , Navas M ,Dan M . Pharmacognostic studies on Pellionia heyneana. J tropical med plant Dec-2004; 5, p. 259-261.
17. Kulkarni SK. Hand Book of Experimental Pharmacology. 3rd ed. New Delhi: Valalbh Prakashan; 1999.
18. F. Yang, X. C. Li, H. Q. Wang and C. R. Yang. Flavonoid glycosides from Colebrookea oppositifolia. Phytochemistry, 1996, 42:867-869.
19. S. A. Aziz, S. A. Siddiqui and A. Zaman, flavones from Colebrookea oppositifolia .Indian J. Chem., 1974, 12:1327-1328.
20. S. A. Patwardhan and A. S. Gupta, Indian J. Chem., 1981, 20B, 627.
21. S. Ansari, M. P. Dhobal, R. P. Tyagi, B. C. Jhoshi and F. S. K. Barar, Pharmazie, 1982, 37, 70.
22. P. K. Mukherjee, K. Mukherjee, A. C. J. H. Lokkerbol, R. Verpoorte and B. Suresh, J. Nat. Remedies, 2001, 1:21-24.
23. R.V. N. Reddy, B. A. K. Reddy and D. Gunasekar, J. Asian Nat. Prod. Res., 2009, 11:183-186.
24. S. Tyagi, S. Saraf, A. C. Ojha and G. S. Rawat, Asian J. Chem., 1995, 7:165-170.
25. R. S. Gupta, R. K. Yadav, V. P. Dixit and M. P. Dobhal, Fitoterapia, 2001, 72:70.
26. K. Joshi, R. Joshi and A. R. Joshi, Indian J. Tradit. Know., 2011, 10:281-286.
27. S. P. Singh, S. K. Singh and S. C. Tripathi, Indian Perfume, 1983, 27:171-173.
28. J. Holley and K. Cherla, In Medicinal and aromatic plants program in Asia.; Christ opher Samuel Artstock, New Delhi, 1998, 109.
29. V. Madhavan • D.K. Yadav • A. Murali • S.N. Yoganarasimhan.Wound healing activity of aqueous and alcohol extracts of leaves of Colebrookea oppositifolia Smith. Indian drugs, 2009; 36(3):209-13.
30. S.Dash, S.B. Bhise, D. Dhachinamoorthi. Effect of aqueous extract of Colebrookea oppositifolia on Bioavailaibility of Amoxycilline in rabbits.Indian drugs, 2004; (4):231-35.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).